Literature DB >> 1949613

Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy.

K Kawaguchi1, S Fujii, I Konishi, T Iwai, Y Nanbu, H Nonogaki, Y Ishikawa, T Mori.   

Abstract

Immunohistochemical distribution of oestrogen receptors (ER), progesterone receptors (PR), and the cell proliferation-associated antigen Ki-67 was investigated in leiomyomas and the myometrium during the menstrual cycle and pregnancy. In the myometrium, ER expression was observed in the proliferative phase, but was suppressed in the secretory phase and during pregnancy. In leiomyomas, ER expression was observed throughout the menstrual cycle, but was suppressed during pregnancy. However, PR was expressed both in the myometrium and leiomyomas throughout the menstrual cycle and pregnancy. In both the myometrium and leiomyomas, a higher number of Ki-67-positive cells was observed during pregnancy than in the secretory phase, and Ki-67 was negative during menopause. The Ki-67-positive cell count in leiomyomas was significantly higher than that in the myometrium throughout the menstrual cycle and pregnancy. Thus both myometrium and leiomyomas have high growth activity under the hormonal milieu of high progesterone levels. The growth potential of leiomyomas is apparently higher than that of myometrium throughout the menstrual cycle and during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949613     DOI: 10.1007/bf01606522

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  16 in total

1.  Immunohistochemical localization of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle.

Authors:  T Iwai; Y Nanbu; M Iwai; S Taii; S Fujii; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Purification of T47D human progesterone receptor and immunochemical characterization with monoclonal antibodies.

Authors:  G L Greene; K Harris; R Bova; R Kinders; B Moore; C Nolan
Journal:  Mol Endocrinol       Date:  1988-08

3.  Immunocytochemical study of progesterone receptors in the human endometrium during the menstrual cycle.

Authors:  C Bergeron; A Ferenczy; D O Toft; W Schneider; G Shyamala
Journal:  Lab Invest       Date:  1988-12       Impact factor: 5.662

4.  Nuclear localization of unoccupied oestrogen receptors.

Authors:  W V Welshons; M E Lieberman; J Gorski
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

5.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

6.  Comparison of cellular levels of steroid receptors in uterine leiomyoma and myometrium.

Authors:  T Tamaya; J Fujimoto; H Okada
Journal:  Acta Obstet Gynecol Scand       Date:  1985       Impact factor: 3.636

7.  Unconjugated steroids in leiomyomas and tumor-bearing myometrium.

Authors:  J A Otubu; V C Buttram; N F Besch; P K Besch
Journal:  Am J Obstet Gynecol       Date:  1982-05-15       Impact factor: 8.661

Review 8.  Dynamics of steroid hormone receptor action.

Authors:  B S Katzenellenbogen
Journal:  Annu Rev Physiol       Date:  1980       Impact factor: 19.318

9.  Monoclonal antibodies as probes for estrogen receptor detection and characterization.

Authors:  G L Greene; E V Jensen
Journal:  J Steroid Biochem       Date:  1982-03       Impact factor: 4.292

10.  Estrogen and progesterone binding proteins in normal human myometrium and leiomyoma tissue.

Authors:  K Pollow; J Geilfuss; E Boquoi; B Pollow
Journal:  J Clin Chem Clin Biochem       Date:  1978-09
View more
  18 in total

1.  Anatomical variation of the oestrogen receptor in the non-neoplastic myometrium of fibromyomatous uteri.

Authors:  P A Richards; A J Tiltman
Journal:  Virchows Arch       Date:  1996-08       Impact factor: 4.064

Review 2.  The role of progesterone signaling in the pathogenesis of uterine leiomyoma.

Authors:  J Julie Kim; Elizabeth C Sefton
Journal:  Mol Cell Endocrinol       Date:  2011-06-06       Impact factor: 4.102

Review 3.  Role of nuclear progesterone receptor isoforms in uterine pathophysiology.

Authors:  Bansari Patel; Sonia Elguero; Suruchi Thakore; Wissam Dahoud; Mohamed Bedaiwy; Sam Mesiano
Journal:  Hum Reprod Update       Date:  2014-11-18       Impact factor: 15.610

4.  Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.

Authors:  Erica N Nierth-Simpson; Melvenia M Martin; Tung-Chin Chiang; Lilia I Melnik; Lyndsay V Rhodes; Shannon E Muir; Matthew E Burow; John A McLachlan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 5.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

6.  Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development.

Authors:  Ayako Suzuki; Masatoshi Kariya; Noriomi Matsumura; Tsukasa Baba; Haruhiko Yagi; Masaki Mandai; Ikuo Konishi; Shingo Fujii
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

7.  Smooth muscle tumor of the placenta - an entrapped maternal leiomyoma: a case report.

Authors:  Katja Murtoniemi; Elina Pirinen; Marketta Kähkönen; Nonna Heiskanen; Seppo Heinonen
Journal:  J Med Case Rep       Date:  2009-06-17

Review 8.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

9.  Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway.

Authors:  Binny V Varghese; Faezeh Koohestani; Michelle McWilliams; Arlene Colvin; Sumedha Gunewardena; William H Kinsey; Romana A Nowak; Warren B Nothnick; Vargheese M Chennathukuzhi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-02       Impact factor: 11.205

10.  Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.

Authors:  Lauren A Wise; Julie R Palmer; Bernard L Harlow; Donna Spiegelman; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2004-01-15       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.